Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Big 3 Generic Firms Log 5.9% Sales Increase in FY2019, with Contraction in Overseas Business: Jiho Tally
June 9, 2020
- Bayer HIF-PH Inhibitor Molidustat Filed in Japan in Q1
June 9, 2020
- Japan Team to Develop Nafamostat Inhaler Formulation for COVID-19
June 9, 2020
- Fujifilm’s Avigan COVID-19 Trial Might Continue into July
June 9, 2020
- Chugai Files FoundationOne as Lynparza CDx for mCRPC
June 8, 2020
- Meiji Pharma Jettisons Nail Ringworm Med ME1111
June 8, 2020
- Opdivo Gets Taiwan Nod for Second-Line Esophageal Cancer
June 8, 2020
- Ono Kicks Off Japan Clinical Study for Pancreatitis Med Foipan for COVID-19
June 8, 2020
- Rakuten Medical, MD Anderson Pair Up on Cancer Photoimmunotherapy
June 8, 2020
- Eylea Pre-Filled Syringe Now Available in Japan: Bayer, Santen
June 8, 2020
- Nipro Launches Stemirac Manufacturing Facility in Tokyo
June 8, 2020
- Latuda to Finally Hit Japan Market on June 11
June 5, 2020
- Opdivo Top-Selling Drug in May, Keytruda Falls to Second: Encise
June 5, 2020
- Kyowa Kirin Looks to Make Crysvita 1st In-House Blockbuster, Sees 100 Billion Yen Target “Not Unachievable”
June 5, 2020
- Humira Remains Global Top-Seller in 2019
June 4, 2020
- Lilly Expects Topline Data for 2 COVID-19 Drug Candidates by June-End, First Patient Dosed in Antibody Treatment Study: Japan Execs
June 3, 2020
- Shionogi Aims at 500 Billion Yen Sales in FY2024: New 5-Year Plan
June 3, 2020
- Kyowa Hakko Bio’s GMP Breach Triggers Shipment Curbs, Stockouts at Astellas, Kowa; Impact Could Reverberate Further
June 3, 2020
- Asahi Kasei Pharma Grabs China Approval for Flivas
June 3, 2020
- Eisai’s Insomnia Med Dayvigo Now Available in US
June 3, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…